Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women

  • Tell a FriendPrint

This post-marketing study will provide local safety and tolerance data on the use of Premarin® vaginal cream...

Brief Summary

Official Title: “A Postmarketing Surveillance Study Evaluating the Tolerability and Safety of PREMARIN VAGINAL CREAM in Indian Postmenopausal Women”

This post-marketing study will provide local safety and tolerance data on the use of Premarin® vaginal cream.

  • Study Type: Observational
  • Study Design: N/A

Intervention(s) in this Clinical Trial

  • Drug: Conjugated Estrogen Cream (Premarin®)

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • Patients in whom Premarin vaginal cream is indicated.
  • In the opinion of the investigator, sufficient intelligence and motivation for the patient to continue throughout the study.
  • Provide signed informed consent.

Exclusion Criteria:

  • Patients not willing to give informed consent.

Gender Eligibility for this Clinical Trial: Female

Minimum Age for this Clinical Trial: 40 Years

Maximum Age for this Clinical Trial: 65 Years

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Clinical Trial Investigator Information

Lead Investigator: Wyeth is now a wholly owned subsidiary of Pfizer Industry

Overall Clinical Trial Officials and Contacts

Medical Monitor Study Director Wyeth is now a wholly owned subsidiary of Pfizer  

Additional Information

Information obtained from ClinicalTrials.gov on February 12, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00484107

Study ID Number: 0713V-101833

ClinicalTrials.gov Identifier: NCT00484107

Health Authority: India: Ministry of Health

  • Tell a FriendPrint

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00484107